belongs to the class of N-heterocyclic polynuclear aromatic metabolic activation to an electrophilic species to exert its hydrocarbons formed during the incomplete combustion of mutagenic and carcinogenic effects. One-electron oxidation, organic matter. As such, it is a component of a variety leading to the formation of radical cation intermediates, of complex mixtures including tobacco smoke condensate, has been proposed as a mechanism of metabolic activation synthetic coal fuels, shale oil, polluted river sediments and for DBC in vitro resulting in unstable DNA adducts. The coal tar (5). It is tumorigenic and carcinogenic in a number of purpose of this research was to determine whether onedifferent species including mouse, rat, hamster and dog (6). It electron oxidation is a mechanism of activation and DNA is an extremely potent liver carcinogen producing mainly binding for DBC in vivo. Specific depurinating DBC-DNA hepatocellular adenomas and carcinomas (7). Like many carciadducts formed by one-electron oxidation were analyzed nogens, DBC requires metabolic activation to exert its mutain mouse liver at 4 h following a single i.p. dose of genic and carcinogenic effects (8). The metabolic profile of 40 mg/kg of 11 µCi [ 14 C]DBC. In addition to five previously DBC is unique, resulting in the formation of primarily phenol published adduct standards, two newly identified adduct intermediates (9). The 3-OH metabolite of DBC has been standards were characterized by mass spectrometry and proposed as a proximate genotoxicant in the activation of DBC NMR, namely DBC-6-N7-Ade and DBC-6-N1-Ade; howto bind to DNA (10). However, the low ionization potential, ever, neither was observed in mouse liver. Only the 7.3 eV (11) of DBC indicates that one-electron oxidation and DBC-5-N7-Gua adduct was observed in mouse liver the formation of radical cation intermediates is another possible extracts at a level of 6.5 ⍨ 1.8 adducts/10 6 nucleotides. In mechanism of activation. addition, the formation of AP sites and stable DBC-DNA Chen et al. (12) demonstrated that DBC is activated by oneadducts was analyzed in mouse liver and lung at 4, 12 and electron oxidation in vitro following microsomal or horse-24 h following a single i.p. dose of 0.4, 4 or 40 mg/kg DBC radish peroxidase (HRP) metabolism in the presence of DNA.
was purchased from Dojindo Inc. (Kumamoto, Japan). Deuterated-DMSO nitrile/water, 0.1% trifluoroacetic acid (0.5-1.0 µl). A nitrogen laser (337 nm λ, 4 ns pulse width, 40 µJ/pulse) was used to desorb the sample ions. For containing 0.1% tetramethylsilane (TMS) was purchased from Aldrich (Milwaukee, WI). All other reagents were purchased from either Fisher NMR analysis, purified adducts were dissolved in deuterated DMSO:0.1% tetramethylsilane and analyzed with a 600 MHz NMR apparatus (Innova 600) Scientific (Pittsburgh, PA) Animal treatment The samples were immediately applied to a supported nitrocellulose membrane Female Hsd:Icr(Br) mice were purchased from Harlan Sprague-Dawley presoaked in 20ϫ SSC using a slot blot vacuum filter apparatus. The filter (Indianapolis, IN) at 4-6 weeks of age and allowed to acclimate for 1 week was rinsed in 5ϫ SSC for 15 min at 37°C, dried and baked in a vacuum oven prior to treatment. Animals were given food and water ad libitum and housed at 80°C for 1 h. The membrane was then blocked with 10 ml Tris-NaCl individually in plastic shoebox cages. Mice (n ϭ 3) were given [ 14 C]DBC in buffer containing BSA (20 mM Tris-HCl, 0.1 M NaCl, 1 mM EDTA, 0.5% corn oil (11 µCi; 40 mg/kg) by i.p. administration. The animals were killed casein, 0.25% BSA, 0.1% Tween-20, pH 7.5) at room temperature for 1 h.
after 4 h and liver and lung tissue harvested and quickly frozen in liquid The membrane was then incubated in the same solution containing streptavidinnitrogen. In a separate experiment, mice were given one bolus dose of DBC conjugated HRP at room temperature for 30 min. After rinsing the membrane in corn oil (0.4, 4.0 or 40 mg/kg) or vehicle control by i.p. injection. Animals with washing buffer (0.26 M NaCl, 1 mM EDTA, 20 mM Tris-HCl, 0.1% were killed by CO 2 inhalation at 4, 12 or 24 h following treatment. Liver and Tween-20, pH 7.5) for 15 min, enzymatic activity was measured using ECL lung were removed and quickly frozen in liquid nitrogen. detection reagents and visualized by incubating with film for 5-45 s. The Soxhlet extraction resulting bands on film were quantitated by image analysis using a Chemimager 4000 (Alpha Innotech) and Chemimager software.
Liver tissue (1 g) from mice treated with [ 14 C]DBC was pulverized under liquid nitrogen. The tissue was extracted with a soxhlet extraction apparatus 32 P-post-labeling-nuclease P1
for 48 h using~20 ml of a mixture of chloroform:methanol (1:1). The extract Duplicate DNA samples were hydrolyzed to 3Ј-monophosphate nucleotides was evaporated to dryness under vacuum. The residue was dissolved in DMSO by incubating with 0.25 U micrococcal nuclease and 2.5 µg spleen phosphodiesby placing in a sonicator for 1-2 h. Another aliquot of tissue was homogenized terase at 37°C for 6 h. Each mixture was incubated with 10 µl nuclease P1 in PBS and analyzed for DNA content by Hoechst 33258 (15) . cocktail (0.6 µg/µl nuclease P1, 0.054 mM ZnCl 2 , 0.075 M NaOAc) for HPLC analysis 5 min. Each mixture was incubated with 5 µl post-labeling cocktail containing 1.5 µl PNK-buffer (200 mM Bicine, 100 mM DTT, 10 mM Spermidine, 100
The [ 14 C]DBC liver extracts were assayed for the presence of adenine or mM MgCl 2 ), 0.28 µl polynucleotide kinase (10.7 U/µl) and 20 µCi [ 32 P]ATP guanine depurinating adducts by HPLC. The extracts were separated by a in 10 mM Bicine pH 9.6 at 37°C for 40 min. Subsequently, each sample was YMC ODS-AQ (6ϫ250 mm) analytical column in an acetonitrile:water or treated with 3 µl apyrase (6.7 U/ml). Aliquots (18 µl) of each sample were methanol:water gradient at 1 ml/min. For the acetonitrile:water gradient, the applied to the origin 1.5 cm from the bottom of a PEI cellulose TLC plate.
column was eluted with 40% acetonitrile in water for 5 min followed by a linear gradient to 100% acetonitrile in 60 min. For the methanol:water gradient, Thin-layer chromatography the column was eluted with 40% methanol in water for 5 min followed by a A 30 cm Whatman filter paper wick was attached to the top of the plate and convex (CV5) gradient to 100% methanol in 60 min. A Waters HPLC system developed in the D1 direction in 0.65 M sodium phosphate pH 6.0 overnight. equipped with a 616 pump, 996 photodiode array detector, U6K manual The plates were rinsed, and each origin was excised and transferred to separate injector, 600S solvent controller and a Shimadzu RF-535 fluorescence detector 10ϫ10 cm PEI plates using a magnet-transfer technique. Plates were developed was used to perform the analysis. An aliquot of each extract was separated in the D3 direction with D3 solvent (3.6 M lithium formate, 8.5 M urea pH and fractions were collected at 0.5 min intervals. Each fraction was analyzed 3.5) followed by removal of the D1 transfer plate and two rinses in deionized by scintillation spectrometry. Due to low levels of the putative depurinating water. The plates were dried, turned 90°in the D4 direction and developed adducts in each of the liver extracts, the remaining extracts from each animal with D4 solvent (0.8 M LiCl, 0.5 M Tris, 8.5 M urea, pH 8) . The plates were were pooled and injected on HPLC collecting 0.5 min fractions. These then rinsed twice, dried and developed in the same direction with D5 solvent fractions were analyzed by fluorescence spectrometry. Fractions corresponding (1.5 M sodium phosphate monobasic, pH 6.0). The plates were dried, marked to the retention time and fluorescence spectra of known standards were with fluorescent crayon and assembled into film cassettes. Plates were exposed reinjected on the acetonitrile:water gradient, collected and again analyzed by to Fujichrome film overnight and developed.
fluorescence spectrometry. The same fraction was then reinjected on a DBC-DNA adduct standard synthesis and identification methanol:water gradient. Synthesis of adenine and guanine positional isomer adducts of DBC by iodine Fluorescence spectra oxidation was conducted according to a method described by Chen et al. (12) .
Fluorescence spectra were analyzed using an Hitachi F-4500 fluorescence Briefly, DBC (1 mmol) and deoxyguanosine (10 mmol) or adenine (5 mmol) spectrophotometer. Fluorescence excitation spectra were recorded at an emiswere dissolved in 15 ml anhydrous dimethylformamide to which iodine (3 sion wavelength of 400 nm and fluorescence emission spectra were recorded mmol/ml) was added dropwise with stirring. The mixture was heated to 50°C
at an excitation wavelength of 278 nm. Synchronous scans of both standard for 4 h under nitrogen, cooled and aqueous sodium thiosulfate added to and unknown peaks were achieved using a delta wavelength (∆λ) corresponding remove the brown iodine color. The dried reaction mix was extracted three to their individual Stokes shift. times with a mixture of ethanol/chloroform/acetone (2:1:1). Individual adducts DNA isolation were purified by HPLC using a YMC ODS-AQ 5 µm column (10ϫ250) and a Waters HPLC system. The column was eluted with a gradient of 40% Liver or lung tissue was homogenized in 1% SDS-100 mM EDTA to which proteinase K (0.2 mg) was added and incubated for 3 h at 55°C (post-labeling) acetonitrile in water for 5 min followed by a linear gradient to 100% acetonitrile in 60 min. Purified adducts were analyzed by mass spectrometry or 12 h at 4°C (ARP assay). RNase A (0.24 mg) and RNase T 1 (40 µg) were then added and the mixture incubated for 30 min at 37°C. The homogenate and NMR. Mass spectrometry was conducted on a MALDI-TOF mass spectrometer (Micromass, TOFSE). Samples were mixed (1:1) with a saturated was cooled on ice followed by protein precipitation with 5 M ammonium acetate. The supernatant was transferred to a new tube and DNA precipitated solution containing α-cyanol-4-OH cinnamic acid dissolved in 50% aceto- DNA hydrolysis DNA (2 µg) was hydrolyzed to 3Ј-monophosphates using 2.5 µg calf spleen phosphodiesterase and 0.25 U micrococcal endonuclease. The hydrolysis mixture was incubated for 6 h at 37°C.
P-post-labeling-carrier-free
The hydrolyzed DNA was labeled at the 5Ј position using 200 µCi [γ-32 P]ATP and 1.7 U polynucleotide kinase at pH 9.0 and incubated for 40 min at 37°C. Samples were applied to the origins of poly(ethyleneimine)-cellulose (PEI) plates. Chromatography was carried out as outlined above.
Results

Comparison of stable adducts versus AP sites following oneelectron oxidation activation of DBC in vitro
In this study, the formation of AP sites as measured by the ARP slot blot method was compared with the level of stable DNA adducts detected by 32 P-post-labeling following activation of DBC by HRP in vitro. (Figure 1 ) There was a dose-dependent increase in both AP sites and stable DBC-DNA adducts, indicating that the response was a function of the amount of DBC binding to DNA. A marked difference was observed between the number of stable DNA adducts versus the number of AP sites in all treatment groups (Figure 1) . A 6-18 fold excess of stable adducts compared with AP sites were noted between concentrations of 1-100 µM DBC. These results are clearly different than other reports which demonstrate that activation of DBC in vitro by HRP metabolism leads to a ratio of 2:1 depurinating observed by HPLC; however, only the DBC-5-N7-Gua adduct adducts to stable adducts as measured by fluorescence line was confirmed by mass spectrometry and 1 H-NMR. narrowing spectroscopy and 32 P-post-labeling, respectively DBC-6-N7-Ade (12).
The spectra of this adduct suggest substitution between the 6 DNA adduct standards position of DBC and the N7 position of adenine ( Figure 2B ). The synthesis of monosubstituted positional isomers of DBC The shielding effect of the NH 2 (Ade) resulting in a broad and adenine or guanine was carried out by iodine oxidation. singlet at δ5.91 is indicative of substitution at the N7 position In addition to the four expected adenine adducts, two additional of adenine. The upfield shift of the 8H doublet coupled with adducts were observed, namely DBC-6-N7-Ade and DBC-6-an absence of shielding effect on the 4H doublet implies N1-Ade. In all, six adenine adducts were observed by HPLC substitution at the 6 position. separation and confirmed by retention times (Table I) , MALDI-DBC-6-N1-Ade TOF mass spectrometry and 1 H-NMR according to previously published data (12), including DBC-5-N7Ade, DBC-5-N3Ade,
The characteristics of this adduct suggest substitution at the 6 position of DBC and the N1 position of adenine ( Figure 2C ). DBC-5-N1Ade, DBC-6-N3Ade. Several guanine peaks were A downfield shift of the 5H proton, upfield shift of the 8H Dose/time-response of stable DBC-DNA adducts in mouse proton in conjunction with an absence of shielding effect on liver and lung the 4H doublet, indicate substitution at the 6 position of DBC. Two-dimensional TLC autoradiograms ( Figure 6 ) depict liver A deshielding effect on the 2H(Ade) proton resulting in a and lung DBC-DNA adducts following a single i.p. administradownfield shift and a shielding effect on the 6-NH 2 (Ade) tion of 0 or 40 mg/kg. As expected, seven stable adducts were resulting in resonance to a downfield position is indicative of detected in mouse liver whereas three were observed in lung substitution at the N1 position of adenine. following i.p. administration. Adducts were numbered to Identification of DBC-DNA adducts in mouse liver correspond to previously published reports (15); however, an Liver extracts from mice (n ϭ 3) treated with [ 14 C]DBC additional adduct positioned adjacent to adduct 1 was observed (40 mg/kg; 11 µCi) were separated by analytical HPLC using in the present study that had not been observed previously an acetonitrile:water gradient. A minor peak was observed at (15) , designated here as adduct 1a. In addition, adduct 4 was 24.6 min that corresponds to the retention time (24.6 min) of not observed in this study. The major adducts in liver were the DBC-5-N7-Gua standard (Table I ). This peak was observed adducts 6, 5 and 3. In lung, the major adducts were 2 and 3. in each of the treated animals ( Figure 3A) . When HPLC DNA adducts were not observed in the control animals in fractions of each liver extract were collected, radioactivity was either tissue. associated with this peak ( Figure 3B ). The retention time of
There was a distinct dose-response between treatment the unknown peak was the same as the standard, DBC-5-N7-groups. As dose increased by log intervals (i.e. 0.4, 4.0 and Gua. Upon reinjection of the fraction and standard, separately, 40.0 mg/kg) the differences in DBC-DNA adduct levels, as onto the acetonitrile:water gradient the same retention times measured by 32 P-post-labeling, increased by approximately the were observed ( Figure 4A ). When this fraction was again same magnitude (Figures 7 and 8 ). In addition, a change in injected on the methanol:water gradient, the retention time adduct level was observed as a function of time. At the highest was identical to that of the standard, DBC-5-N7-Gua (Figure dose in liver, the RAL index continued to increase for all 4B). Comparison of fluorescence spectra of the DBC-5-N7-adducts up to 24 h, whereas at the mid and low doses, RAL Gua standard and the unknown fraction gave identical results appears to be either declining or approaching a plateau by ( Figure 5) . Peaks corresponding to the other adduct standards 24 h. At all doses in lung tissue, DNA adducts appear to be were not observed in the liver extracts, but they may be below our limits of detection.
increasing up to 24 h.
Dose/time-response of AP sites in mouse liver and lung following DBC administration in vivo
AP sites were observed in both liver and lung DNA ( Figures  9 and 10 ). While there was not a clear dose-response in all treatment groups, the number of AP sites in liver DNA were elevated at both 4 and 12 h post dosing at the mid and high dose groups. A significant increase of AP sites in liver DNA was observed (P ഛ 0.05) following the 4.0 and 40.0 mg/kg DBC treatment groups at 4 and 12 h, respectively, post-dosing. A statistically significant increase in AP sites was not observed in the lung DNA of treated animals.
Discussion
The interaction between metabolic activation and DNA damage is important in understanding basic mechanisms leading to mutagenesis and carcinogenesis by genotoxic compounds. This study has investigated whether one-electron oxidation is a mechanism of metabolism for the carcinogen DBC, resulting in the formation of unstable DNA adducts and AP sites in vitro and in vivo. This is a novel pathway of metabolic activation that has been largely supported by Cavalieri et al. (2, 12) . The significance of this pathway is presumed to be related to the levels of unstable DNA adducts produced in target tissues such as mouse skin (3, 4) . The resulting DNA damage from an unstable DNA adduct is an AP site. While AP sites are the most frequent spontaneous lesion in DNA, they are also mutagenic (13, 14) . The results of this work indicate that oneelectron oxidation of DBC leading to the formation of unstable DBC-DNA adducts occurs in vitro and in mouse liver. This is quantitatively a minor (0.4%) pathway of activation and DNA binding. DBC-DNA adducts compared with stable DNA adducts in vitro (12). While the components and timing of the in vitro reactions were similar to other studies (12), it is not clear as to why such a quantitative discrepancy exists. Certainly different methodologies were used to quantitate the resulting DNA damage, i.e. measuring AP sites directly versus indirectly by quantitating specific depurinating DNA adducts. In addition, interlaboratory variability in absolute adduct levels exists with the 32 P-post-labeling assay and may help to explain some of the quantitative differences observed between other studies (12) and the data presented here. Overall, the data presented here support the idea that unstable DNA adducts may be a minor mechanism of DNA damage by one-electron oxidation compared with stable DNA adducts in vitro. Synthesis of DBC adenine adducts by iodine oxidation yielded the expected products namely, DBC-5-N7-Ade, DBC-5-N3-Ade, DBC-6-N3-Ade, DBC-5-N1-Ade and DBC-5-N7-Gua. Two additional adducts were also observed including DBC-6-N7-Ade and DBC-6-N1-Ade. Interestingly, the 5 or 6 positions of DBC were the only positions bound to adenine or guanine by iodine oxidation. This may indicate that charge density is localized at either of these positions.
Radical cation intermediates have been proposed as the and DBC (4, 3, 12, 17) . Of these compounds only B[a]P has Chromatograms were exposed to film for 2-18 h.
been examined both in vitro and in mouse skin, the major somal enzymes, suggested that this mechanism of activation may be occurring in the target tissues relevant to DBC. Only the DBC-5-N7-Gua adduct was observed in mouse liver extracts at a level of 6.5 Ϯ 1.9 depurinating adducts/10 6 nucleotides. It has been proposed that for many PAHs, the major depurinating DNA adducts may reflect mutation specificity. For example, the major B[a]P-guanyl adduct is presumed to be a major intermediate in production of G→T mutations. However, the major base-substitution mutation observed following DBC administration in mouse lung is an A→T transversion. This type of mutation does not support a role for the involvement of the unstable DBC-5-N7-Gua adduct observed in mouse liver. This does not exclude the possibility that mutations may mutations (14). It is not known, however, whether the amount of damage produced by this mechanism would result in an increased frequency of mutations. target organ for B[a]P-induced skin tumors (4) . The major adducts observed in skin were the depurinating B[a]P-DNA If one-electron oxidation participates in the activation of DBC in its target tissues, specific depurinating adducts and adducts formed by a one-electron oxidation mechanism and not the diol-epoxide pathway of activation. These observations AP sites would be the primary DNA damage produced through this mechanism. AP sites are not detected by the method of were intriguing because they contradicted a long held belief that the diol-epoxide pathway is the only route of activation 32 P-post-labeling used for DBC-DNA adduct analysis. This suggests that while stable DBC-DNA adducts are detected in for B[a]P. In addition, the implications of this work suggested that a very different type of DNA damage, namely AP sites, the target tissues liver, lung and skin, other types of DNA damage may be occurring that cannot be identified by may contribute to the mutagenic and carcinogenic potency of B[a]P in mouse skin. The finding that DBC was activated by 32 P-post-labeling analysis.
The number of AP sites detected in mouse liver DNA one-electron oxidation, not only by HRP but also by micro-and stable DNA adducts detected by 32 P-post-labeling were compared in mouse liver at the 40 mg/kg dose group and 4 h time point. Stable adducts outnumber AP sites or the DBC-5-N7-Gua adduct by roughly 300:1 ( Figure 11 ). This observation clearly demonstrates that the stable DBC-DNA adducts detected by 32 P-post-labeling are a major type of DNA damage. The unstable adduct was detected; however, it occurs at levels much lower than stable adducts. This indicates that oneelectron oxidation leading to the formation of unstable DNA adducts and AP sites is not a major mechanism of DNA damage by DBC. Fig. 11 . Comparison of AP sites, stable adducts and the DBC-5-N7-Gua
